Latest News & Features
Careers
A regulatory counsel with nine years at the FDA and over two decades of patent experience at a US law firm in Washington DC, bringing expertise across the pharma and biotech sectors. 24 November 2025
Europe
Clients sending “masses of AI content” to patent attorneys is a growing problem, says the man leading the UK association’s AI Committee. Sarah Speight reports. 24 November 2025
Americas
The USPTO’s ‘settled expectations’ rule is anything but settled, argues Andrew Zappia of Troutman Pepper Locke. 24 November 2025
Europe
The week exposed fractures in the UK's industry—but also unexpected reasons for optimism. Five themes dominated conversations about the direction of the country's life sciences sector. 21 November 2025
Europe
The country’s public health service has replaced its IP framework with a nine-step plan, as the government tries to reposition the UK as a global life sciences leader. 20 November 2025
Americas
A PTAB dispute over $29.5bn drug reaches a dramatic conclusion, at a critical time ahead of the drug's US patent expiration. 20 November 2025
Big Pharma
A new report from Clarivate highlights a jump in the tech’s adoption among IP professionals over the past two years, as well as concerns over governance. 20 November 2025
Americas
President-elect Deborah Hampton says she is looking forward to advancing the association’s advocacy work in the new year, and implementing its 2026–2029 plan. 20 November 2025
Americas
The court rules that Duke University and Allergan’s patent lacked sufficient written description, in the wake of stricter post-Amgen Section 112 standards. 19 November 2025
Careers
The combination will create a firm with 3,000 lawyers across 52 offices—but a dive into its combined IP practice shows a heavy weighting in the US. 18 November 2025